A detailed history of Geode Capital Management, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,378,758 shares of CORT stock, worth $137 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,378,758
Previous 2,279,288 4.36%
Holding current value
$137 Million
Previous $74.1 Million 48.6%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$29.51 - $46.26 $2.94 Million - $4.6 Million
99,470 Added 4.36%
2,378,758 $110 Million
Q2 2024

Aug 09, 2024

BUY
$22.21 - $34.48 $2.7 Million - $4.19 Million
121,503 Added 5.63%
2,279,288 $74.1 Million
Q1 2024

May 13, 2024

BUY
$21.1 - $27.46 $2.37 Million - $3.08 Million
112,139 Added 5.48%
2,157,785 $54.4 Million
Q4 2023

Feb 13, 2024

BUY
$24.82 - $32.88 $2.18 Million - $2.89 Million
87,959 Added 4.49%
2,045,646 $66.4 Million
Q3 2023

Nov 13, 2023

BUY
$21.97 - $33.8 $4.68 Million - $7.2 Million
212,897 Added 12.2%
1,957,687 $53.3 Million
Q2 2023

Aug 11, 2023

SELL
$21.44 - $25.15 $1.05 Million - $1.24 Million
-49,137 Reduced 2.74%
1,744,790 $38.8 Million
Q1 2023

May 15, 2023

BUY
$19.2 - $24.47 $1.39 Million - $1.77 Million
72,426 Added 4.21%
1,793,927 $38.9 Million
Q4 2022

Feb 13, 2023

BUY
$19.95 - $29.96 $1.49 Million - $2.24 Million
74,718 Added 4.54%
1,721,501 $35 Million
Q3 2022

Nov 14, 2022

BUY
$24.7 - $29.12 $427,458 - $503,950
17,306 Added 1.06%
1,646,783 $42.2 Million
Q2 2022

Aug 12, 2022

SELL
$17.33 - $25.3 $648,193 - $946,295
-37,403 Reduced 2.24%
1,629,477 $38.7 Million
Q1 2022

May 13, 2022

SELL
$16.53 - $25.21 $1.06 Million - $1.61 Million
-63,992 Reduced 3.7%
1,666,880 $37.5 Million
Q4 2021

Feb 11, 2022

SELL
$17.1 - $23.34 $1.27 Million - $1.74 Million
-74,533 Reduced 4.13%
1,730,872 $34.3 Million
Q3 2021

Nov 12, 2021

SELL
$19.68 - $22.53 $76,850 - $87,979
-3,905 Reduced 0.22%
1,805,405 $35.5 Million
Q2 2021

Aug 13, 2021

BUY
$19.97 - $24.43 $760,956 - $930,905
38,105 Added 2.15%
1,809,310 $39.8 Million
Q1 2021

May 12, 2021

BUY
$23.49 - $30.56 $2.91 Million - $3.79 Million
123,882 Added 7.52%
1,771,205 $42.1 Million
Q4 2020

Feb 12, 2021

BUY
$16.78 - $27.3 $2.27 Million - $3.69 Million
135,198 Added 8.94%
1,647,323 $43.1 Million
Q3 2020

Nov 13, 2020

SELL
$12.46 - $19.98 $147,389 - $236,343
-11,829 Reduced 0.78%
1,512,125 $26.3 Million
Q2 2020

Aug 13, 2020

BUY
$11.0 - $18.26 $491,623 - $816,094
44,693 Added 3.02%
1,523,954 $25.6 Million
Q1 2020

May 14, 2020

BUY
$10.11 - $14.04 $471,682 - $655,036
46,655 Added 3.26%
1,479,261 $17.6 Million
Q4 2019

Feb 13, 2020

BUY
$12.06 - $16.96 $195,456 - $274,870
16,207 Added 1.14%
1,432,606 $17.3 Million
Q3 2019

Nov 12, 2019

BUY
$10.41 - $14.66 $332,360 - $468,049
31,927 Added 2.31%
1,416,399 $20 Million
Q2 2019

Aug 14, 2019

BUY
$9.78 - $12.76 $1.22 Million - $1.59 Million
124,903 Added 9.92%
1,384,472 $15.4 Million
Q1 2019

May 14, 2019

BUY
$10.03 - $15.71 $847,886 - $1.33 Million
84,535 Added 7.19%
1,259,569 $14.8 Million
Q4 2018

Feb 13, 2019

BUY
$11.29 - $17.19 $967,609 - $1.47 Million
85,705 Added 7.87%
1,175,034 $15.7 Million
Q3 2018

Nov 13, 2018

BUY
$12.27 - $15.65 $1.35 Million - $1.72 Million
110,170 Added 11.25%
1,089,329 $15.3 Million
Q2 2018

Aug 14, 2018

BUY
$15.3 - $19.69 $1.54 Million - $1.99 Million
100,904 Added 11.49%
979,159 $15.4 Million
Q1 2018

May 15, 2018

SELL
$14.59 - $25.5 $978,916 - $1.71 Million
-67,095 Reduced 7.1%
878,255 $14.4 Million
Q4 2017

Feb 13, 2018

SELL
$15.77 - $20.72 $277,662 - $364,817
-17,607 Reduced 1.83%
945,350 $17.1 Million
Q3 2017

Nov 14, 2017

BUY
$12.3 - $19.3 $1.21 Million - $1.9 Million
98,635 Added 11.41%
962,957 $18.6 Million
Q2 2017

Aug 14, 2017

BUY
N/A
864,322
864,322 $10.2 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.16B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.